Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score.
Morten WürtzKevin Kris Warnakula OlesenMartin Bødtker MortensenJohn William EikelboomMoman Aladdin MohammadDavid ErlingeSteen Dalby KristensenMichael MaengPublished in: European heart journal (2021)
Based on the 2019 ESC guidelines, dual antithrombotic treatment should be considered in one-third of CCS patients. The CHADS-P2A2RC score improved risk classification and may particularly identify low-risk patients with limited benefit from treatment.